RPG Life Sciences hits record high on Q1 profit jump

By Aditya Bhagchandani Published on July 22, 2024, 11:33 IST

RPG Life Sciences shares surged up to 14.81% to a 52-week high of ₹2,057.15 per share on the BSE in Monday’s intraday trading.

Key Financial Highlights

– Revenue from Operations: Grew 12% year-on-year (YoY) to ₹165.42 crore in Q1 FY25 from ₹147.78 crore in Q1 FY24.
– Profit After Tax: Rose 21% YoY to ₹26.76 crore in Q1 FY25 from ₹22.10 crore in Q1 FY24.
– EBITDA Margin: Improved from 23.0% to 25.1% YoY.

The stock saw a significant trading volume, with more than 280,000 shares traded, 7.1 times the 30-day average. It rose 7.5% in the June quarter, marking the fifth straight quarterly gain.

Managing Director Yugal Sikri attributed the success to cost optimization and strategic modernization of both API and Formulations plants. The company aims to bolster its international formulations and API businesses as new growth engines.

As of 11:30 AM, the shares were trading 8.11% higher at ₹1,940.00 on the NSE.

RPG Life Sciences

Aditya Bhagchandani

Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.